Evotec (OTCMKTS:EVTCY) Reaches New 12-Month Low – Here’s What Happened

Evotec SE (OTCMKTS:EVTCY) shares hit a new 52-week low during mid-day trading on Monday . The company traded as low as $4.62 and last traded at $4.72, with a volume of 74379 shares changing hands. The stock had previously closed at $4.69.

Evotec Stock Performance

The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $1.51 billion, a price-to-earnings ratio of 11.17 and a beta of 0.98. The company has a 50-day moving average of $4.39 and a 200-day moving average of $4.30.

Evotec Company Profile

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.